Genpact Limited carries a market capitalization of 5.48B, placing it among publicly traded companies globally. Its enterprise value stands at 7.26B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.48B |
| Enterprise Value | 7.26B |
Genpact Limited currently has 169.50M shares outstanding.
| Shares Outstanding | 169.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Genpact Limited trades at a trailing price-to-earnings ratio of 11.29. The price-to-sales ratio is 1.25, and the price-to-book ratio stands at 4.47.
| PE Ratio | 11.29 |
| PS Ratio | 1.25 |
| PB Ratio | 4.47 |
| P/TBV Ratio | 10.08 |
| P/FCF Ratio | 7.71 |
| P/OCF Ratio | 8.58 |
On an enterprise value basis, Genpact Limited trades at an EV/EBITDA multiple of 8.35 and an EV/FCF ratio of 8.02. The EV/Sales ratio of 1.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.36 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.41 |
| EV / EBITDA | 8.35 |
| EV / EBIT | 9.36 |
| EV / FCF | 8.02 |
Genpact Limited maintains a current ratio of 1.69, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 71.02, indicating elevated leverage, while an interest coverage ratio of 11.21 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.69 |
| Quick Ratio | 1.56 |
| Debt / Equity | 71.02 |
| Debt / EBITDA | 2.02 |
| Interest Coverage | 11.21 |
Genpact Limited posts a return on equity of 41.97 and a return on invested capital of 14.43.
| Return on Equity (ROE) | 41.97 |
| Return on Assets (ROA) | 10.84 |
| Return on Invested Capital (ROIC) | 14.43 |
| Return on Capital Employed (ROCE) | 21.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Genpact Limited has paid 179.29M in income taxes, reflecting an effective tax rate of 23.94.
| Income Tax | 179.29M |
| Effective Tax Rate | 23.94 |
Genpact Limited's stock has declined approximately -24.42677% over the past 52 weeks. The 50-day moving average sits at 34.47, while the 200-day moving average is 40.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.42677% |
| 50-Day Moving Average | 34.47 |
| 200-Day Moving Average | 40.66 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Genpact Limited generated 5.16B in revenue and converted that into 569.63M in net income, yielding earnings per share of 3.25. EBITDA reached 869.76M, while operating income came in at 775.17M.
| Revenue | 5.16B |
| Gross Profit | 1.87B |
| Operating Income | 775.17M |
| Pretax Income | 748.92M |
| Net Income | 569.63M |
| EBITDA | 869.76M |
| EBIT | 775.17M |
| Earnings Per Share (EPS) | 3.25 |
Genpact Limited holds 928.08M in cash and equivalents against 1.76B in total debt, resulting in a net debt position of 958.26M. Total book value stands at 1.44B, with working capital of 979.00M providing operational flexibility.
| Cash & Cash Equivalents | 928.08M |
| Total Debt | 1.76B |
| Net Debt | 958.26M |
| Equity (Book Value) | 1.44B |
| Book Value Per Share | 8.33 |
| Working Capital | 979.00M |
Genpact Limited produced 748.89M in operating cash flow over the past twelve months. After subtracting -97.39M in capital expenditures, free cash flow totaled 651.49M - equivalent to 3.77 per share.
| Operating Cash Flow | 748.89M |
| Capital Expenditures | -97.39M |
| Free Cash Flow | 651.49M |
| FCF Per Share | 3.77 |
Genpact Limited operates with a gross margin of 36.30, reflecting its pricing power and cost economics. The operating margin of 15.02 and net profit margin of 11.04 provide insight into operational efficiency.
| Gross Margin | 36.30 |
| Operating Margin | 15.02 |
| Pretax Margin | 14.51 |
| Profit Margin | 11.04 |
| EBITDA Margin | 16.85 |
The company's payout ratio of 21.02 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.69 |
| Dividend Yield | N/A |
| Payout Ratio | 21.02 |
| Shareholder Yield | 2.89 |
| FCF Yield | 12.96 |
Genpact Limited posts an Altman Z-Score of 4.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.11 |